Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Goodwill: 2018-2024

Historic Goodwill for OptimizeRx (OPRX) over the last 7 years, with FY2024 value amounting to $70.9 million.

  • OptimizeRx's Goodwill fell 4.37% to $70.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.9 million, marking a year-over-year decrease of 4.37%. This contributed to the annual value of $70.9 million for FY2024, which is 955.63% down from last year.
  • Latest data reveals that OptimizeRx reported Goodwill of $70.9 million as of FY2024, which was down 955.63% from $78.4 million recorded in FY2023.
  • Over the past 5 years, OptimizeRx's Goodwill peaked at $78.4 million during FY2023, and registered a low of $14.7 million during FY2020.
  • Moreover, its 5-year median value for Goodwill was $22.7 million (2022), whereas its average is $40.3 million.
  • In the last 5 years, OptimizeRx's Goodwill soared by 24558.08% in 2023 and then plummeted by 955.63% in 2024.
  • OptimizeRx's Goodwill (Annual) stood at $14.7 million in 2020, then changed by 0.0% to $14.7 million in 2021, then surged by 53.83% to $22.7 million in 2022, then skyrocketed by 245.58% to $78.4 million in 2023, then fell by 9.56% to $70.9 million in 2024.
  • Its Goodwill was $70.9 million in FY2024, compared to $78.4 million in FY2023 and $22.7 million in FY2022.